National Association of Boards of Pharmacy (NABP) · MPJE Competency Statements applicable on 2026-10-11 and through 2027-02-28. The inspected current page does not state their original effective date. NABP's replacement MPJE Content Outline, published in 2026, takes effect 2027-03-01 and is not used for this set. The workbook label matches the official state-specific MPJE name; the assigned slug is preserved. The Uniform MPJE has a separate outline and is not substituted.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• NABP — MPJE/UMPJE
• NABP — MPJE Competency Statements
• NABP — MPJE Content Outline announcement, June 10, 2026
• NABP — Multistate Pharmacy Jurisprudence Content Outline, ©2026
• Texas State Board of Pharmacy — Board Rules, September 1, 2026
• 21 CFR 1301.76 — Other security controls for practitioners
• 21 CFR 1306.06 — Persons entitled to fill prescriptions
• 21 CFR 1306.03 — Persons entitled to issue prescriptions
• 21 CFR Part 1306 — Prescriptions
• 21 CFR 1306.22 — Refilling of prescriptions
• 21 CFR 1306.11 — Requirement of prescription
• 45 CFR 164.506 — Treatment, payment and health care operations disclosures
• HHS — Minimum Necessary Requirement
• 42 CFR 456.705 — Prospective drug review
• 21 CFR 1306.04 — Purpose of issue of prescription
• 21 CFR 1306.08 — Electronic prescriptions
• DEA — Electronic Prescriptions for Controlled Substances Q&A
• CPSC — Poison Prevention Packaging: A Text for Healthcare Professionals
• 21 CFR 1314.20 — Restrictions on sales quantity
• DEA — Combat Methamphetamine Epidemic Act Overview and Requirements, December 4, 2025
• 21 CFR 1306.13 — Partial filling of prescriptions
• 21 CFR 1304.11 — Inventory requirements
• 21 CFR 1305.03 — Distributions requiring a Form 222 or digitally signed electronic order
• FDA — FD&C Act Provisions that Apply to Human Drug Compounding